Bristol-Myers Squibb Co. - Celgene Contingent Value Rights

Company Profile

bristol-myers squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. our medicines are helping millions of patients around the world in their fight against cancer, cardiovascular disease, hepatitis b, hiv/aids and rheumatoid arthritis. the bristol-myers squibb foundation’s philanthropic programs seek to promote health equity and improve the health outcomes among populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people. over the past decade, we have delivered 14 new products to patients with serious diseases. four of these products are biologic products. additional biologic compounds – as well as scores of other investigational medicines – are advancing through the development pipeline. bristol-myers squibb is recognized as having one of the most productive r&d pipelines in the industry. to a